United States — Food and Drug Administration & Donald Trump
45 shared events · Importance 13 · Last updated May 13, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing a leadership change with the resignation of its Commissioner, Marty Makary, and the appointment of Kyle Diamantas as acting chief. The agency has faced internal clashes, policy confusion, and criticism during Marty Makary's tenure.
Donald Trump: Donald Trump signed off on the plan to fire Marty Makary and publicly acknowledged his departure, citing 'difficulty' Marty Makary was experiencing. Donald Trump's administration will now need to fill another high-level vacancy.
May 08, 2026 · 35 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration>>> is the agency undergoing a significant leadership change with the planned ouster of its Commissioner Marty Makary>>>, which has led to low morale and high-profile departures.
Donald Trump: Donald Trump, as President of the United States, has signed off on the plan to fire Marty Makary>>> from his position as FDA Commissioner, indicating his direct involvement in the leadership change.
May 08, 2026 · 7 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is undergoing a leadership change with Marty Makary's resignation and Kyle Diamantas taking over as acting commissioner, potentially signaling shifts in regulatory policy.
Donald Trump: Donald Trump confirmed Marty Makary's resignation and appointed Kyle Diamantas as acting commissioner, indicating his influence on the United States — Food and Drug Administration's leadership and policy direction.
May 12, 2026 · 8 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration experienced significant leadership turnover, low staff morale, and unpredictable regulatory shifts under Marty Makary's leadership, leading to uncertainty for regulated industries.
Donald Trump: Donald Trump appointed Marty Makary and later confirmed his resignation, facing pressure from various political allies regarding the United States — Food and Drug Administration's regulatory decisions.
May 12, 2026 · 32 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration's regulations regarding mifepristone access were challenged, and the agency is conducting a safety review of the medication.
Donald Trump: Donald Trump's first-term nominations set the stage for the United States — Supreme Court of the United States that voted to overturn Roe v. Wade. He faces pressure from anti-abortion groups to restrict mifepristone access, while also seeking to steer clear of the issue.
May 04, 2026 · 52 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing leadership changes with Dr. Marty Makary's resignation and Kyle Diamantas taking over as acting commissioner.
Donald Trump: Donald Trump's presidency is weighed down by the war with Iran and rising inflation. He is seeking trade deals with China and is pushing for a 'Golden Dome' missile defense program.
May 13, 2026 · 6 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration advises against the use of ibuprofen after 20 weeks of pregnancy, making acetaminophen a common alternative for pregnant women, which is relevant to the discussion around Tylenol.
Donald Trump: Donald Trump publicly supported Robert F. Kennedy Jr.'s unproven claims about Tylenol and autism, urging pregnant women and parents not to use the pain reliever, which drew criticism from medical experts.
Oct 09, 2025 · 9 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration's regulations allowing mail-order mifepristone were overruled by the United States — United States Court of Appeals for the Third Circuit, despite the agency's long-standing judgments on drug safety.
Donald Trump: Donald Trump's administration approved a generic version of mifepristone, drawing criticism from anti-abortion advocates who expressed frustration over his inaction to block the pill's distribution.
May 01, 2026 · 78 articles
International
United States — Food and Drug Administration: Marty Makary is resigning as head of the United States — Food and Drug Administration after facing complaints from various groups and internal staff.
Donald Trump: Donald Trump is departing for Beijing to meet with Xi Jinping to discuss the Iran war and other issues, while his administration faces questions about the war's cost and weapons stockpiles.
May 12, 2026 · 9 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing significant leadership changes, including the removal of Tracy Beth Høeg and the resignation of Marty Makary and Vinay Prasad, which could impact its regulatory direction and stability.
Donald Trump: Donald Trump's political allies expressed frustration with the United States — Food and Drug Administration's direction, contributing to Marty Makary's ouster.
May 16, 2026 · 10 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration approved Eli Lilly and Company's weight loss pill, Foundayo, impacting the pharmaceutical market.
Donald Trump: Donald Trump's comments about a potential end to the Middle East conflict influenced market sentiment, leading to speculation about peace.
Apr 01, 2026 · 14 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration experienced leadership shake-ups, with its top drug official, Dr. Tracy Beth Høeg, being fired and Commissioner Marty Makary resigning.
Donald Trump: Donald Trump, the President of the United States, dismissed Iran's ceasefire proposal, demanded a rollback of Iran's nuclear activities, announced a joint mission with Nigeria against the Islamic State group, and returned from China to face escalating inflation and political challenges.
May 16, 2026 · 7 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is conducting a new review of mifepristone's safety, and a court panel is requiring in-person distribution of the pill.
Donald Trump: Donald Trump is the President of the United States and a central figure in the ongoing negotiations with Iran, the imposition of tariffs on the European Union, and the approval of the Bridger Pipeline LLC Expansion. His decisions directly influence these events.
May 01, 2026 · 6 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration is undergoing a significant shake-up with the departure of key officials like Tracy Beth Høeg and Marty Makary, and the United States — White House exerting more control over its policies.
Donald Trump: Donald Trump's second term is mentioned as the period during which Tracy Beth Høeg served as the fifth person to run the Center for Drug Evaluation and Research.
May 15, 2026 · 6 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing leadership changes with the resignation of Marty Makary, leading to uncertainty about the fate of various initiatives.
Donald Trump: Donald Trump is the President of the United States and a key decision-maker in the ongoing war with Iran. His administration's policies and budget requests are central to the event, and he is facing pressure due to the economic impact of the conflict.
May 12, 2026 · 49 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration's rule allowing mifepristone to be prescribed online and dispensed through the mail was temporarily halted by an appellate court, but later paused by the United States — Supreme Court of the United States. The agency is conducting a safety review of mifepristone.
Donald Trump: The Trump administration has been pressured by antiabortion advocates to reimpose limits on mifepristone, but has sidestepped those demands, pledging only that the United States — Food and Drug Administration would conduct a safety review.
May 04, 2026 · 6 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration faces a leadership void after Marty Makary's resignation, leaving unfinished initiatives and ongoing reviews under scrutiny. Its ability to balance regulatory interests with new health policies is challenged.
Donald Trump: Donald Trump is mentioned as a friend of Kyle Diamantas, who was tapped by Donald Trump to lead the United States — Food and Drug Administration on an acting basis.
May 13, 2026 · 6 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is mentioned as having a commissioner, Marty Makary, who also hosts a podcast, providing context for the novelty of a cabinet secretary hosting one.
Donald Trump: Donald Trump's administration appointed Robert F. Kennedy Jr. as Health Secretary, and the podcast initiative has been in the works since early in his second administration.
Apr 08, 2026 · 15 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration was directed by Donald Trump to issue new guidance on acetaminophen and approved leucovorin for autism treatment, facing scrutiny for its scientific basis.
Sep 22, 2025 · 6 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is expected to notify doctors about a potential association between acetaminophen and autism, a recommendation that lacks immediate medical evidence and is controversial.
Sep 22, 2025 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Neuralink 'breakthrough device' designation for its technology, expediting its development and review.
May 27, 2025 · 8 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is one of the agencies occupying offices whose leases were initially slated for termination by the Department of Government Efficiency (DOGE) but have since been spared.
Sep 23, 2025 · 10 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration advised doctors to consider minimizing acetaminophen's use in pregnancy, amid inconclusive evidence about a link to autism.
Nov 03, 2025 · 10 articles
+ 15 more events
View on Dashboard
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Donald Trump interact across events, view sentiment trends, and discover connected entities.
Open Dashboard